PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,526 | -36.2% | 9,532 | -34.9% | 0.00% | – |
| Q2 2023 | $91,703 | +195.0% | 14,649 | +124.7% | 0.00% | – |
| Q1 2023 | $31,091 | +35.2% | 6,518 | +245.2% | 0.00% | – |
| Q3 2022 | $23,000 | -43.9% | 1,888 | -33.6% | 0.00% | – |
| Q2 2022 | $41,000 | -14.6% | 2,842 | +23.4% | 0.00% | – |
| Q1 2022 | $48,000 | -81.1% | 2,303 | -79.1% | 0.00% | – |
| Q4 2021 | $254,000 | +25300.0% | 11,027 | +29702.7% | 0.00% | – |
| Q3 2021 | $1,000 | – | 37 | +311.1% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 9 | -99.7% | 0.00% | – |
| Q1 2021 | $103,000 | -76.4% | 3,107 | -56.1% | 0.00% | – |
| Q4 2020 | $436,000 | – | 7,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |